openPR Logo
Press release

Rising Dementia Cases to boost the Global Alzheimer’s Disease Therapeutics and Diagnostics Market

12-21-2021 12:06 PM CET | Health & Medicine

Press release from: Inkwood Research

Global Alzheimer?s Disease Therapeutics and Diagnostics Market

Global Alzheimer?s Disease Therapeutics and Diagnostics Market

According to a new market research report launched by Inkwood Research, the Global Alzheimer’s Disease Therapeutics and Diagnostics Market is estimated to attain $9979.0 million by 2028, growing at a CAGR of 5.40% during the years 2021-2028.

Browse across 51 market data Tables and 46 Figures spread over 225 Pages, along with in-depth analysis on Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Therapeutics and Diagnostics & Geography.

This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market by assessing major geographies and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.

Global Alzheimer’s Disease Therapeutics and Diagnostics Market Scenario
The high incidence rate of Alzheimer’s disease acts as a major driver for the market as it highlights the need to develop an effective treatment. As per estimates, a significant amount of the global population suffers from Alzheimer’s dementia. This number of expected to grow in the upcoming years, owing to the rise in the geriatric population. Additionally, around two-thirds of the women suffer from the disease in the US. Hence, the surge in Alzheimer’s prevalence among the older population is expected to boost the demand for therapeutics and diagnostics services, thereby driving the global market on a growth path.

Furthermore, several novel diagnostics technologies have been identified to treat Alzheimer’s, including a technology that detects mutated proteins in subcellular compartments. This invention also defines these mutations that result in the redistribution of vital cellular organelles. Hence, the launch of innovative diagnostics technologies further fuels the market’s development.

The Global Alzheimer’s Disease Therapeutics and Diagnostics Market report provides data tables and includes charts and graphs for visual analysis.
Request Free Sample Report for Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Therapeutics and Diagnostics & Geography: https://www.inkwoodresearch.com/reports/alzheimers-disease-therapeutics-and-diagnostics-market/#request-free-sample

Market Segmentation
Market by Therapeutics and Diagnostics
Therapeutics
Therapeutics by Generic and Branded
Generic
Branded
Therapeutics by Drugs
Pipeline Drugs
Marketed Drugs
Therapeutics by Disease Stage
Early/Middle Stage: Mild to Moderate Ad
Late Stage: Severe Ad
Prodromal Stage
Diagnostics
Electroencephalography
Blood Test
Magnetic Resonance Imaging
Positron Emission Tomography
Computed Tomography
Lumbar Puncture Test
Other Diagnostics

Report Highlights
- The report provides a detailed analysis of the current and future market trends to identify the investment opportunities
- Market forecasts till 2028, using estimated market values as the base numbers
- Key market trends across the business segments, regions, and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities, and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2028

Companies Profiled
HOFFMANN-LA ROCHE
GE HEALTHCARE
ALLERGAN PLC (ACQUIRED BY ABBVIE)
NOVARTIS AG
LUPIN LIMITED
ZYDUS CADILA
AMARANTUS BIOSCIENCE HOLDINGS INC
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
SIEMENS HEALTHINEERS AG
SUN PHARMACEUTICALS INDUSTRIES LTD
COGNOPTIX INC
JOHNSON & JOHNSON
BIOGEN INC
BAXTER INTERNATIONAL INC
PFIZER INC
EISAI CO LTD
MERCK & CO INC
ELI LILLY & COMPANY

Related Reports
GLOBAL STEM CELL MARKET - The global stem cell market will evolve at a growth rate of 7.82% during the forecast period.

GLOBAL NEUROREHABILITATION DEVICE MARKET - The global neurorehabilitation device market is expected to grow at a CAGR of 15.12% during the forecasted period 2021-2028.

GLOBAL KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET - The global kidney cancer therapeutics and diagnostics market is anticipated to progress at a growth rate of 5.52% over the forecast period.

Inkwood Research
169, Harrison Avenue
Boston, MA 02111
Tel: 1-(857)293-0150
Email: sales@inkwoodresearch.com
Website: www.inkwoodresearch.com

We at Inkwood research provide you with not just consulting services but also with syndicated and customized research reports which help advance your business further.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Dementia Cases to boost the Global Alzheimer’s Disease Therapeutics and Diagnostics Market here

News-ID: 2506529 • Views:

More Releases from Inkwood Research

United States Wood Coatings Market Analysis 2024-2032
United States Wood Coatings Market Analysis 2024-2032
Inkwood Research states that the United States Wood Coatings Market is expected to achieve a compound annual growth rate (CAGR) of 5.02% during the forecast period of 2024-2032, with projected revenues reaching $xx million by 2032. This growth is driven by a combination of factors, including increasing construction activities, rising consumer preference for aesthetically appealing wood products, and advancements in coating technologies. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/united-states-wood-coatings-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR Prominent companies in the
Rising Uptake of Industry 4.0 to Amp Motion Control Market Growth
Rising Uptake of Industry 4.0 to Amp Motion Control Market Growth
As per a new market research report launched by Inkwood Research, the Global Motion Control Market is predicted to reach $26041.29 million by 2032, growing at a CAGR of 5.13% during the forecasting period, 2024-2032. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/global-motion-control-market-forecast-2024-2032/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects
Rise in Golf Tourism to Elevate Golf Cart Market Growth
Rise in Golf Tourism to Elevate Golf Cart Market Growth
As per a new market research report launched by Inkwood Research, the Global Golf Cart Market is expected to grow at a CAGR of 5.68% during the forecasting period, 2024-2032. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/golf-cart-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market by
Government Rules to Promote the Growth of the Electric Vehicle Power Inverter Market
Government Rules to Promote the Growth of the Electric Vehicle Power Inverter Ma …
As per a new market research report launched by Inkwood Research, the Global Electric Vehicle Power Inverter Market is expected to reach $34868.78 million by 2032, growing with a CAGR of 14.36% during the forecasting period, 2024-2032. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/electric-vehicle-power-inverter-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant